WO2021031348A1 - Milk-based liquid infant formula containing active proteins, and preparation method therefor - Google Patents

Milk-based liquid infant formula containing active proteins, and preparation method therefor Download PDF

Info

Publication number
WO2021031348A1
WO2021031348A1 PCT/CN2019/114535 CN2019114535W WO2021031348A1 WO 2021031348 A1 WO2021031348 A1 WO 2021031348A1 CN 2019114535 W CN2019114535 W CN 2019114535W WO 2021031348 A1 WO2021031348 A1 WO 2021031348A1
Authority
WO
WIPO (PCT)
Prior art keywords
milk
infant formula
based infant
preparing
preparation
Prior art date
Application number
PCT/CN2019/114535
Other languages
French (fr)
Chinese (zh)
Inventor
周鹏
刘要卫
张文锦
张丽娜
Original Assignee
江南大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 江南大学 filed Critical 江南大学
Publication of WO2021031348A1 publication Critical patent/WO2021031348A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/152Milk preparations; Milk powder or milk powder preparations containing additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/152Milk preparations; Milk powder or milk powder preparations containing additives
    • A23C9/1522Inorganic additives, e.g. minerals, trace elements; Chlorination or fluoridation of milk; Organic salts or complexes of metals other than natrium or kalium; Calcium enrichment of milk
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/152Milk preparations; Milk powder or milk powder preparations containing additives
    • A23C9/1526Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/152Milk preparations; Milk powder or milk powder preparations containing additives
    • A23C9/1528Fatty acids; Mono- or diglycerides; Petroleum jelly; Paraffine; Phospholipids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/152Milk preparations; Milk powder or milk powder preparations containing additives
    • A23C9/156Flavoured milk preparations ; Addition of fruits, vegetables, sugars, sugar alcohols or sweeteners
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/152Milk preparations; Milk powder or milk powder preparations containing additives
    • A23C9/158Milk preparations; Milk powder or milk powder preparations containing additives containing vitamins or antibiotics

Definitions

  • the invention relates to a milk-based infant formula liquid milk containing active protein and a preparation method thereof, and belongs to the technical field of dairy products.
  • breast milk is the most ideal natural food for infants and young children, and it is also the gold standard for infant formula milk powder.
  • infant formula milk powder represented by cow milk and goat milk has become the main diet and nutrition source for contemporary newborns.
  • the nutritional value of common infant formula milk powder or normal temperature infant formula liquid milk on the market cannot be compared with breast milk, because breast milk is naturally rich in immunologically active substances, such as immunoglobulins (including IgA, IgG and IgM, etc.), Lactoferrin, enzymes, and hundreds of low-abundance proteins, these low-abundance proteins often have life activities such as regulating immunity and promoting metabolism.
  • immunoglobulins including IgA, IgG and IgM, etc.
  • Lactoferrin lactoferrin
  • enzymes enzymes
  • these low-abundance proteins often have life activities such as regulating immunity and promoting metabolism.
  • IgA plays an important role in protecting newborns from intestinal and respiratory pathogenic microbial infections (Hanson and Korotkova, 2002).
  • IgG and IgM also play an important role in the defense of the intestinal mucosa of infants.
  • IgG can bind to viruses to lure pathogens or prevent them from adhering to the mucosal surface (Robert-Guroff, 2000).
  • infant formula powder generally can only simulate breast milk as much as possible in terms of macronutrients, such as adjusting the ratio of casein to whey protein, and adjusting the types of fatty acids, but it is difficult for active proteins such as immunoglobulins and other important functions The level of low-abundance protein to simulate breast milk.
  • Troost et al. (2001) and Jasion (2015) showed that lactoferrin and immunoglobulin in milk can avoid gastrointestinal digestion, and play a very important role in maintaining the body's antibacterial, anti-inflammatory, and enhancing immunity.
  • heat treatment is the most common processing method in the processing of raw milk, and the processing and inactivation of active proteins in raw milk is an important problem in the current dairy industry.
  • the lactoferrin and immunoglobulin in dairy products are often heat-sensitive.
  • the preparation of infant formula powder often requires a series of high temperature treatments, such as sterilization, concentration, and spray drying.
  • the normal temperature infant formula liquid milk also undergoes ultra-high temperature sterilization.
  • the biological activity of the functional protein is almost completely lost, and a large number of low-abundance proteins in the whey are reduced, resulting in a greatly reduced nutritional value.
  • Zhang Yanjie disclosed an infant formula milk powder containing lactoferrin and probiotics and its preparation method (publication number: CN108029768A), in which additional lactoferrin still needs to be added manually.
  • Most of the commercially available lactoferrin is a purified imported product, which is extremely scarce and expensive, and it is prone to protein denaturation during the purification process, thereby losing its biological activity.
  • the purpose of the present invention is to provide a method for preparing milk-based liquid formula milk for infants and young children containing active protein.
  • the preparation method includes mixing, homogenizing, and heat sterilizing liquid fresh milk or goat milk with other nutrients.
  • Heat sterilization treatment is to use pasteurization at 72 ⁇ 75 °C for 15 ⁇ 20 s or 63 ⁇ 65 °C for 30 ⁇ 40 min.
  • the preparation method includes the following steps:
  • step (3) Mix whey protein powder, plant blended oil, lactose, phospholipids, DHA and ARA with purified water to dissolve it, stir thoroughly and mix with fresh milk or goat milk evenly, so that the resulting mixture contains whey protein powder, The content of plant blend oil, lactose, phospholipid, DHA and ARA meet the calculation results in step (2);
  • step (2) Dissolve the compound mineral premix and compound vitamin premix with purified water respectively, add step by step to the mixture obtained in step (3) and mix thoroughly, add compound minerals and compound vitamins
  • step (3) Dissolve the compound mineral premix and compound vitamin premix with purified water respectively, add step by step to the mixture obtained in step (3) and mix thoroughly, add compound minerals and compound vitamins
  • step (3) Dissolve the compound mineral premix and compound vitamin premix with purified water respectively, add step by step to the mixture obtained in step (3) and mix thoroughly, add compound minerals and compound vitamins
  • step (3) Dissolve the compound minerals and compound vitamins
  • the active protein refers to lactoferrin, immunoglobulin IgG, IgA, IgM, lactoperoxidase, complement protein C3, ribonuclease, lipocalin-2 , Lactagglutinin or its combination.
  • the nutrients include whey protein powder, vegetable oil, lactose, phospholipids, DHA, ARA, compound minerals and compound vitamins.
  • step (1) determines the content of minerals in cow milk or goat milk by inductively coupled plasma mass spectrometry ICP-MS.
  • the whey protein powder is added to make the ratio of whey protein to casein in milk ⁇ 3: 2, the ratio of protein in milk is close to the ratio of protein in breast milk, and the total protein content is 1.0 ⁇ 2.5 g/100 mL.
  • the temperature of the purified water in step (3) and step (4) is 40-50°C.
  • the whey protein powder, vegetable oil, minerals, vitamins, inositol, choline, taurine, DHA and ARA required to be added to the formula milk meet the national food safety standard GB The standard specified by 10765-2010.
  • the homogenization condition is 20-30 MPa, homogenize for 1 to 2 times.
  • Another object of the present invention is to provide infant formula milk prepared by the above-mentioned milk-based infant formula liquid milk preparation method with improved active protein retention rate.
  • Another object of the present invention is to provide the application in the food field of the method for preparing milk-based infant liquid formula milk for improving the retention of active protein.
  • the present invention uses fresh milk (bovine milk or goat milk) as the main raw material, adjusts the ratio of protein, fat and carbohydrate in the milk, and adds vitamins and minerals to better simulate the breast milk formula.
  • the present invention compares the effects of different heat treatment processes on the active protein in milk, and finally selects the pasteurization method to complete the sterilization of the milk, thereby developing a pasteurized infant liquid formula with active protein .
  • Figure 1 (a) Preparation process of liquid infant formula milk and (b) experimental process of liquid mass protein group (LC-MS/MS).
  • FIG. 1 The effect of different heat treatment methods on the retention of active protein in fresh milk.
  • FIG. 3 The effect of different heat treatment methods on the retention of active protein in fresh goat milk.
  • Figure 4 Electrophoresis patterns of whey protein in fresh milk after different heat treatments.
  • FIG. 5 Heat map (A) and principal component analysis map (B) of whey protein group in infant formula liquid milk after different heat treatment.
  • Figure 6 Volcano graph of whey protein group in samples of high temperature treatment group (E, U, S) and low temperature treatment group (L, H) (p ⁇ 0.05).
  • weight percentage it includes the following components: 25% fresh milk, 0.95% whey protein powder, 5.75% lactose, 2.58% vegetable blend oil (in terms of mass percentage, including the following raw material components: soybean oil 45%, corn oil 40 %, canola oil 5%, high oleic sunflower oil 5%, coconut oil 5%), compound mineral 0.13% (based on mass percentage, including the following raw material components: anhydrous copper sulfate 0.62% , Potassium iodate 5.40%, ferrous sulfate 16.86%, magnesium sulfate 49.35%, zinc sulfate 7.33%), compound vitamin 0.48% (by mass percentage, including the following raw material components: retinyl acetate 1.23%, cholecalcification Alcohol 0.71%, alpha-tocopherol acetate 4.58%, plant menadione 0.16%, thiamine nitrate 0.15%, riboflavin 0.07%, pyridoxine hydrochloride 0.12%,
  • Step 1 Take fresh milk and measure the protein, lactose, milk fat and minerals in the milk;
  • Step 2 Calculate the content of macronutrients in infant formula milk based on the nutrient requirements of infants aged 6-12 months;
  • Step 3 Use 40-50 for whey protein powder, vegetable oil, lactose, phospholipids, DHA and ARA Mix and dissolve in pure water at °C and stir thoroughly;
  • Step 4 Dissolve the compound mineral premix and compound vitamin premix in each special container with purified water at 40 ⁇ 50°C, and add them step by step to the mixture of step 1 for thorough mixing and compounding
  • the time for adding and mixing minerals and compound vitamins should be ⁇ 15min, then add inositol, choline, and taurine and mix thoroughly;
  • Step 5 Homogenization: homogenize the above-mentioned mixture at a homogenization pressure of 25-30 MPa, homogenize 1 to 2 times;
  • Step 6 Sterilize the homogenized liquid milk (75°C, 15s);
  • Step 7 Cold chain transportation after aseptic filling, low temperature storage (under 4°C).
  • weight percentage it includes the following components: 25% fresh milk, 1.35% whey protein powder, 8.35% lactose, 2.28% vegetable blend oil (by mass percentage, including the following raw material components: soybean oil 45%, corn oil 40 %, canola oil 5%, high oleic sunflower oil 5%), compound mineral 0.13% (calculated by mass percentage, including the following raw materials: anhydrous copper sulfate 0.62%, potassium iodate 5.40 %, ferrous sulfate 16.86%, magnesium sulfate 49.35%, zinc sulfate 7.33%), compound vitamin 0.48% (by mass percentage, including the following raw material components: retinyl acetate 1.23%, cholecalciferol 0.71%, ⁇ -Tocopherol acetate 4.58%, plant menadione 0.16%, thiamine nitrate 0.15%, riboflavin 0.07%, pyridoxine hydrochloride 0.12%, L-sodium
  • Step 1 Take fresh milk and measure the protein, lactose, milk fat and minerals in the milk;
  • Step 2 Calculate the content of macronutrients in infant formula milk based on the nutrient requirements of infants aged 6-12 months;
  • Step 3 Use 40-50 for whey protein powder, vegetable oil, lactose and phospholipids Mix and dissolve in pure water at °C and stir thoroughly;
  • Step 4 Use 40-50 compound mineral premix and compound vitamin premix in each special container respectively Dissolve in pure water at °C, add step by step to the mixture of step 1 and mix thoroughly.
  • the mixing time for compound minerals and compound vitamins should be ⁇ 15min, and then add inositol, choline, taurine, DHA and ARA , Fully mixed;
  • Step 5 Homogenization: homogenize the above-mentioned mixture at a homogenization pressure of 20-30 MPa, homogenize 1-2 times;
  • Step 6 Sterilize the homogenized liquid milk (75°C, 15s);
  • Step 7 Cold chain transportation after aseptic filling, low temperature storage (under 4°C).
  • weight percentage it includes the following components: 25% fresh goat milk, 0.95% whey protein powder, 5.75% lactose, 2.58% vegetable blend oil (by mass percentage, including the following raw material components: soybean oil 45%, corn oil 40%, canola oil 5%, high oleic sunflower oil 5%, coconut oil 5%), compound mineral 0.13% (based on mass percentage, including the following raw material components: anhydrous copper sulfate 0.62 %, potassium iodate 5.40%, ferrous sulfate 16.86%, magnesium sulfate 49.35%, zinc sulfate 7.33%), compound vitamin 0.48% (by mass percentage, including the following raw material components: retinyl acetate 1.23%, bile Calciferol 0.71%, alpha-tocopherol acetate 4.58%, plant menadione 0.16%, thiamine nitrate 0.15%, riboflavin 0.07%, pyridoxine hydrochloride 0.12%, L-s
  • Step 1 Take fresh goat milk and measure the protein, lactose, milk fat and minerals in the milk;
  • Step 2 Calculate the content of macronutrients in liquid milk formula for infants and young children based on the nutrient requirements of infants aged 6-12 months;
  • Step 3 Use 40-50 for whey protein powder, vegetable oil, lactose, phospholipids, DHA and ARA Mix and dissolve in pure water at °C and stir thoroughly;
  • Step 4 Dissolve the compound mineral premix and compound vitamin premix in each special container with purified water at 40 ⁇ 50°C, and add them step by step to the mixture of step 1 for thorough mixing and compounding
  • the time for adding and mixing minerals and compound vitamins should be ⁇ 15min, then add inositol, choline, and taurine and mix thoroughly;
  • Step 5 Homogenization: homogenize the above-mentioned mixture at a homogenization pressure of 25-30 MPa, homogenize 1 to 2 times;
  • Step 6 Sterilize the homogenized liquid milk (65°C, 30min);
  • Step 7 Cold chain transportation after aseptic filling, low temperature storage (under 4°C).
  • Example 1 the enzyme-linked immunoassay method was used to compare the immunoglobulin (IgA, IgG and IgM) and lactoferrin content in infant formula produced by different processes, and SDS was used at the same time.
  • -Gel electrophoresis and LC-MS/MS proteomics methods to identify the types and content changes of low-abundance proteins in whey protein.
  • the specific test process and result analysis are as follows:
  • Fresh milk was purchased from Wuxi Tianzi Dairy Co., Ltd., Jiangsu province, and the immunoglobulin test kit (Elisa Kit) was purchased from Bethyl Company, USA.
  • the liquid chromatography used for LC-MS/MS was from USA Thermo Fisher Scientific Ultimate 3000 capillary high performance liquid chromatograph, mass spectrometer is Thermo Fisher Scientific Q Exactive Electrospray-Combined Ion Trap Orbitrap Mass spectrometer. All capillary liquid chromatography columns used are PepMap RPLC C18 prepacked column. Mobile phase A: 0.1% formic acid, 2% ACN; mobile phase B: 0.1% formic acid, 80% ACN; flow rate: 300 nL/min.
  • Sterilization conditions were 65°C, 30min (L group), 75°C, 15s (H group), 125°C, 5s (E group), 135°C, 5s (U group) and spray drying (95°C sterilization for 15 minutes, spray Dry, inlet air temperature is 185°C, outlet air temperature is 85°C, S group).
  • the samples of different treatment groups were subjected to ultra-high-speed centrifugation (Beckman, USA) Coulter centrifuge, 100000g, 25°C, 90min) After obtaining the whey, the immunoglobulin and lactoferrin content determination (two parallel holes for each sample), SDS gel electrophoresis experiment, trypsin digestion And LC-MS/MS Proteomics experiment (two parallels for each sample).
  • the enzymolysis operation is as follows:
  • the peptide fragments are desalted using self-packing desalting column. Evaporate the solvent in a vacuum centrifugal concentrator at °C.
  • Two-stage mass spectrometry parameters Resolution: 75,000; AGCtarget: 1e5; MaximumIT: 60 ms;
  • TopN 20; NCE/steppedNCE: 27.
  • Mass spectrometry raw files use Maxquant (1.6.2.10) Search the uniprot-Bos taurus database, and use Uniprot data to search the biological functions of the identified proteins.
  • Table 2 lists the low-abundance whey proteins that have decreased content and lack of loss after high temperature treatment. These proteins mainly include enzymes, complement proteins, structural proteins, etc., and involve many physiological activities such as catalysis, immunity, and adhesion. The results show that the liquid milk formula for infants and young children prepared by the heat treatment method of the present invention retains a higher content of active proteins, such as immunoglobulin, lactoferrin, complement protein, lactectin, etc.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)

Abstract

A milk-based liquid infant formula containing active proteins, preparation method therefor, and a use of the preparation method. Fresh milk is used as a main raw material. According to requirements of the national standard and the standard of breastmilk, the proportions of the protein, fat, and carbohydrate in the milk are regulated; a vitamin and a mineral substance are added; and by means of the comparison of the effects of different heat treatment processes on active proteins in the milk, which mainly comprise immunoglobulins, lactoferrins, and low-abundance proteins in milk serum, the pasteurization method is finally used to sterilize the milk, such that a pasteurized milk-based liquid infant formula having active proteins is developed.

Description

一种含活性蛋白的乳基婴幼儿配方液态奶及其制备方法Milk-based infant formula liquid milk containing active protein and preparation method thereof 技术领域Technical field
本发明涉及一种含活性蛋白的乳基婴幼儿配方液态奶及其制备方法,属于乳制品技术领域。The invention relates to a milk-based infant formula liquid milk containing active protein and a preparation method thereof, and belongs to the technical field of dairy products.
背景技术Background technique
目前市面上出售的婴幼儿配方乳以乳粉形式存在的居多,还有少部分是超高温灭菌后的常温贮藏配方液态乳的形式存在。在将新鲜乳转化为配方乳粉或常温储藏的配方液态奶的过程中,诸多热处理操作会导致乳中的热敏型的活性蛋白质发生变性而丧失其生物活性,如乳铁蛋白、免疫球蛋白、乳凝集素、乳过氧化物酶等等。而这些活性蛋白往往在增强婴幼儿免疫力、提高认知能力、增强体质、降低哮喘等疾病发病率方面发挥重要作用,这些活性蛋白的损失大大降低了乳的其营养价值,且现有的婴幼儿配方乳产品加工手段几乎难以保留鲜乳中的这些活性蛋白。At present, most of the infant formula milk on the market exists in the form of milk powder, and a small part is in the form of liquid milk stored at room temperature after ultra-high temperature sterilization. In the process of converting fresh milk into formula milk powder or formula liquid milk stored at room temperature, many heat treatment operations will cause the heat-sensitive active protein in the milk to denature and lose its biological activity, such as lactoferrin and immunoglobulin , Lactagglutinin, Lactoperoxidase, etc. These active proteins often play an important role in enhancing the immunity of infants and young children, improving cognitive ability, enhancing physical fitness, and reducing the incidence of diseases such as asthma. The loss of these active proteins greatly reduces the nutritional value of milk, and the existing infants The processing methods of infant formula milk products can hardly retain these active proteins in fresh milk.
现代营养学公认,母乳是婴幼儿最理想的天然食品,也是婴幼儿配方奶粉的黄金标准。但是由于工作、健康等原因,大部分母亲不能保证正常的母乳喂养,因此以牛乳、羊乳为代表的婴幼儿配方奶粉成为当代新生的主要饮食和营养来源。Modern nutrition recognizes that breast milk is the most ideal natural food for infants and young children, and it is also the gold standard for infant formula milk powder. However, due to work, health and other reasons, most mothers cannot guarantee normal breastfeeding. Therefore, infant formula milk powder represented by cow milk and goat milk has become the main diet and nutrition source for contemporary newborns.
但是市面上常见的婴幼儿配方奶粉或者常温婴幼儿配方液态乳的营养价值无法与母乳相比,因为母乳中天然含有丰富的免疫活性物质,例如免疫球蛋白(包括IgA、IgG和IgM等)、乳铁蛋白、酶类以及种类高达几百种的低丰度蛋白,这些低丰度蛋白往往具备调节免疫、促进代谢等生活活性。IgA作为人体黏膜免疫的重要抗体之一,在保护新生儿抵御肠道和呼吸道病原微生物感染中起着重要作用(Hanson 和Korotkova,2002)。IgG和IgM在婴儿肠黏膜防御中也发挥着重要作用,IgG可与病毒结合,诱惑病原体或阻止其黏附在黏膜表面(Robert-Guroff,2000)。现阶段,婴幼儿配方粉一般只能在宏量营养素上尽量模拟母乳,比如调整酪蛋白与乳清蛋白的比例,调节脂肪酸的种类,但却很难在免疫球蛋白等活性蛋白及其他重要功能的低丰度蛋白层面去模拟母乳。Troost等人(2001)和Jasion 等人(2015)的研究表明,乳中存在的乳铁蛋白和免疫球蛋白能够避开肠胃的消化作用,在维持机体抗菌、消炎、调高机体免疫力等方面发挥着十分重要的作用。However, the nutritional value of common infant formula milk powder or normal temperature infant formula liquid milk on the market cannot be compared with breast milk, because breast milk is naturally rich in immunologically active substances, such as immunoglobulins (including IgA, IgG and IgM, etc.), Lactoferrin, enzymes, and hundreds of low-abundance proteins, these low-abundance proteins often have life activities such as regulating immunity and promoting metabolism. As one of the important antibodies of human mucosal immunity, IgA plays an important role in protecting newborns from intestinal and respiratory pathogenic microbial infections (Hanson and Korotkova, 2002). IgG and IgM also play an important role in the defense of the intestinal mucosa of infants. IgG can bind to viruses to lure pathogens or prevent them from adhering to the mucosal surface (Robert-Guroff, 2000). At this stage, infant formula powder generally can only simulate breast milk as much as possible in terms of macronutrients, such as adjusting the ratio of casein to whey protein, and adjusting the types of fatty acids, but it is difficult for active proteins such as immunoglobulins and other important functions The level of low-abundance protein to simulate breast milk. Troost et al. (2001) and Jasion (2015) showed that lactoferrin and immunoglobulin in milk can avoid gastrointestinal digestion, and play a very important role in maintaining the body's antibacterial, anti-inflammatory, and enhancing immunity.
现阶段,热处理是生鲜乳在加工过程中最常见的加工方式,生鲜乳中活性蛋白的加工失活是目前乳制品工业中的重要难题。乳制品中的乳铁蛋白、免疫球蛋白等往往是热敏感型的。婴幼儿配方粉的制备往往需要经过一系列的高温处理,如灭菌、浓缩、喷雾干燥等。而常温婴幼儿配方液态乳也要经过超高温灭菌的环节。在这些热处理过程中,其功能蛋白的生物活性几乎全部丧失,并造成乳清中大量低丰度蛋白种类减少,导致其营养价值大大降低。最近,张艳杰公开了一种含乳铁蛋白和益生菌的婴幼儿配方奶粉及其制备方法(公开号:CN108029768A),其中仍需人工额外添加乳铁蛋白。市售的乳铁蛋白多为提纯过的进口产品,极为稀缺且价格昂贵,且在提纯过程中容易发生蛋白变性,从而丧失其生物活性。At this stage, heat treatment is the most common processing method in the processing of raw milk, and the processing and inactivation of active proteins in raw milk is an important problem in the current dairy industry. The lactoferrin and immunoglobulin in dairy products are often heat-sensitive. The preparation of infant formula powder often requires a series of high temperature treatments, such as sterilization, concentration, and spray drying. The normal temperature infant formula liquid milk also undergoes ultra-high temperature sterilization. In these heat treatment processes, the biological activity of the functional protein is almost completely lost, and a large number of low-abundance proteins in the whey are reduced, resulting in a greatly reduced nutritional value. Recently, Zhang Yanjie disclosed an infant formula milk powder containing lactoferrin and probiotics and its preparation method (publication number: CN108029768A), in which additional lactoferrin still needs to be added manually. Most of the commercially available lactoferrin is a purified imported product, which is extremely scarce and expensive, and it is prone to protein denaturation during the purification process, thereby losing its biological activity.
因此,如何开发一款方便饮用、且含有活性蛋白的婴幼儿配方液态奶及其制备方法是本领域亟待解决的一个重要问题。Therefore, how to develop an infant formula liquid milk that is convenient to drink and contains active protein and its preparation method is an important problem to be solved urgently in this field.
技术解决方案Technical solutions
本发明的目的是提供一种含活性蛋白的乳基婴幼儿液态配方乳的制备方法,所述制备方法包括将液态新鲜牛乳或羊乳与其他营养素进行调配、均质、热杀菌处理,所述热杀菌处理是利用巴氏杀菌72~75 ℃处理15~20 s 或63~65 ℃处理30~40 min。The purpose of the present invention is to provide a method for preparing milk-based liquid formula milk for infants and young children containing active protein. The preparation method includes mixing, homogenizing, and heat sterilizing liquid fresh milk or goat milk with other nutrients. Heat sterilization treatment is to use pasteurization at 72~75 ℃ for 15~20 s or 63~65 ℃ for 30~40 min.
在本发明的一种实施方式中,制备方法包括以下步骤:In one embodiment of the present invention, the preparation method includes the following steps:
(1)取新鲜牛乳或羊乳,测定其蛋白质、乳糖、脂肪和矿物质的含量;(1) Take fresh milk or goat milk and determine the content of protein, lactose, fat and minerals;
(2)按照食品安全国家标准GB 10765-2010计算婴幼儿配方液态乳中所需营养素的含量;(2) Calculate the required nutrient content in infant formula liquid milk in accordance with the national food safety standard GB 10765-2010;
(3)将乳清蛋白粉、植物调和油、乳糖、磷脂、DHA和ARA使用纯净水混合溶解,进行充分搅拌后与新鲜牛乳或羊乳混合均匀,使得到的混料中乳清蛋白粉、植物调和油、乳糖、磷脂、DHA和ARA含量符合步骤(2)中的计算结果;(3) Mix whey protein powder, plant blended oil, lactose, phospholipids, DHA and ARA with purified water to dissolve it, stir thoroughly and mix with fresh milk or goat milk evenly, so that the resulting mixture contains whey protein powder, The content of plant blend oil, lactose, phospholipid, DHA and ARA meet the calculation results in step (2);
(4)将复配矿物质预混料、复配维生素预混料分别用纯净水溶解,分步添加到步骤(3)得到的混料中进行充分混合,添加复配矿物质、复配维生素时,混合时间均不低于15 min,再添加肌醇、胆碱、牛磺酸,充分混合,使得到的混料中复配矿物质、复配维生素、肌醇、胆碱、牛磺酸含量符合步骤(2)中的计算结果;(4) Dissolve the compound mineral premix and compound vitamin premix with purified water respectively, add step by step to the mixture obtained in step (3) and mix thoroughly, add compound minerals and compound vitamins When the mixing time is not less than 15 minutes, add inositol, choline, and taurine and mix thoroughly so that the resulting mixture is compounded with minerals, compound vitamins, inositol, choline, and taurine The content meets the calculation result in step (2);
(5)均质;(5) Homogenization;
(6)将均质过的液态奶进行杀菌,利用巴氏杀菌72~75 ℃处理15~20 s 或63~65 ℃处理30~40 min。(6) Sterilize the homogenized liquid milk, use pasteurization at 72~75 ℃ for 15~20 s or 63~65 ℃ for 30~40 min.
在本发明的一种实施方式中,所述活性蛋白指的是乳铁蛋白、免疫球蛋白IgG、IgA、IgM、乳过氧化物酶、补体蛋白C3、核糖核酸酶、脂质运载蛋白-2、乳凝集素或其结合。In one embodiment of the present invention, the active protein refers to lactoferrin, immunoglobulin IgG, IgA, IgM, lactoperoxidase, complement protein C3, ribonuclease, lipocalin-2 , Lactagglutinin or its combination.
在本发明的一种实施方式中,所述营养素包括乳清蛋白粉、植物调和油、乳糖、磷脂、DHA、ARA、复配矿物质和复配维生素。In one embodiment of the present invention, the nutrients include whey protein powder, vegetable oil, lactose, phospholipids, DHA, ARA, compound minerals and compound vitamins.
在本发明的一种实施方式中,步骤(1)通过电感耦合等离子体质谱ICP-MS测定牛乳或羊乳中矿物质的含量。In one embodiment of the present invention, step (1) determines the content of minerals in cow milk or goat milk by inductively coupled plasma mass spectrometry ICP-MS.
在本发明的一种实施方式中,添加乳清蛋白粉使乳中乳清蛋白与酪蛋白比例≥3: 2,乳中蛋白比例接近母乳中的蛋白比例,总蛋白含量在1.0~2.5 g/100 mL。In one embodiment of the present invention, the whey protein powder is added to make the ratio of whey protein to casein in milk ≥3: 2, the ratio of protein in milk is close to the ratio of protein in breast milk, and the total protein content is 1.0~2.5 g/100 mL.
在本发明的一种实施方式中,步骤(3)与步骤(4)中的纯净水温度为40~50℃。In an embodiment of the present invention, the temperature of the purified water in step (3) and step (4) is 40-50°C.
在本发明的一种实施方式中,配方乳中所需添加的乳清蛋白粉、植物调和油、矿物质、维生素、肌醇、胆碱、牛磺酸、DHA和ARA符合食品安全国家标准GB 10765-2010规定的标准。In one embodiment of the present invention, the whey protein powder, vegetable oil, minerals, vitamins, inositol, choline, taurine, DHA and ARA required to be added to the formula milk meet the national food safety standard GB The standard specified by 10765-2010.
在本发明的一种实施方式中,均质条件为20~30 MPa,均质1~2次。In one embodiment of the present invention, the homogenization condition is 20-30 MPa, homogenize for 1 to 2 times.
在本发明的一种实施方式中,杀菌后无菌灌装,冷链运输或低温冷藏。In one embodiment of the present invention, after sterilization, aseptic filling, cold chain transportation or low temperature refrigeration.
本发明的另一个目的是提供上述提高活性蛋白保留率的乳基婴幼儿配方液态奶制备方法制备得到的婴幼儿配方奶。Another object of the present invention is to provide infant formula milk prepared by the above-mentioned milk-based infant formula liquid milk preparation method with improved active protein retention rate.
本发明的另一个目的是提供上述提高活性蛋白保留率的乳基婴幼儿液态配方乳制备方法在食品领域中的应用。Another object of the present invention is to provide the application in the food field of the method for preparing milk-based infant liquid formula milk for improving the retention of active protein.
有益效果Beneficial effect
本发明以新鲜乳(牛乳或羊乳)为主要原料,通过调节乳中蛋白,脂肪和碳水化合物比例,添加维生素和矿物质,来更好地模拟母乳配方。此外,本发明对比了不同的热处理工艺对乳中活性蛋白的影响,最终选择巴氏杀菌的方法完成对乳的杀菌,从而开发了一款具有活性蛋白的巴氏杀菌型的婴幼儿液态配方乳。The present invention uses fresh milk (bovine milk or goat milk) as the main raw material, adjusts the ratio of protein, fat and carbohydrate in the milk, and adds vitamins and minerals to better simulate the breast milk formula. In addition, the present invention compares the effects of different heat treatment processes on the active protein in milk, and finally selects the pasteurization method to complete the sterilization of the milk, thereby developing a pasteurized infant liquid formula with active protein .
附图说明Description of the drawings
图1:(a)液态婴幼儿配方乳制备过程及(b)液质蛋白组(LC-MS/MS)实验流程。Figure 1: (a) Preparation process of liquid infant formula milk and (b) experimental process of liquid mass protein group (LC-MS/MS).
图2:不同的热处理方式对鲜牛乳中活性蛋白保留率的影响。Figure 2: The effect of different heat treatment methods on the retention of active protein in fresh milk.
图3:不同的热处理方式对鲜羊乳中活性蛋白保留率的影响。Figure 3: The effect of different heat treatment methods on the retention of active protein in fresh goat milk.
图4:不同热处理后鲜牛乳中乳清蛋白的电泳图谱。Figure 4: Electrophoresis patterns of whey protein in fresh milk after different heat treatments.
图5:不同热处理后的婴配液态奶中乳清蛋白组的热图(A)和主成分分析图(B)。Figure 5: Heat map (A) and principal component analysis map (B) of whey protein group in infant formula liquid milk after different heat treatment.
图6:高温组处理(E,U,S)与低温处理组(L,H)样品中乳清蛋白组火山图(p<0.05)。Figure 6: Volcano graph of whey protein group in samples of high temperature treatment group (E, U, S) and low temperature treatment group (L, H) (p<0.05).
本发明的实施方式Embodiments of the invention
本发明的实施方式在于更好地解释发明,并非限制本发明的保护范围。本领域的技术人员应该知道,按照本发明说明书的步骤是可以完整无误地实施本发明。如若因为奶源不同(如非鲜奶及乳的产地)而导致活性蛋白保留率有略微差异不应该作为本发明技术方案不一致的理由。The embodiments of the present invention are intended to better explain the invention and do not limit the scope of protection of the present invention. Those skilled in the art should know that the present invention can be implemented without error according to the steps in the description of the present invention. If there is a slight difference in the retention rate of active protein due to different milk sources (such as non-fresh milk and milk producing areas), it should not be used as a reason for inconsistent technical solutions of the present invention.
液态婴幼儿配方乳制备过程及液质蛋白组(LC-MS/MS)实验流程如图1所示。The liquid infant formula milk preparation process and the liquid mass protein group (LC-MS/MS) experimental process are shown in Figure 1.
实施例1Example 1
一种含有活性蛋白的较大婴儿(6-12个月)牛乳基液态配方奶A milk-based liquid formula for older babies (6-12 months) containing active protein
以6~12个月的婴儿营养素需求为标准,以新鲜牛乳、乳清蛋白粉、植物调和油、乳糖为主要原料,添加复合维生素、矿物质、牛磺酸、肌醇、胆碱等。按重量百分比计包括以下组分:鲜牛乳25%、乳清蛋白粉0.95%、乳糖5.75%、植物调和油2.58%(按质量百分比计,包括以下原料组分:大豆油45%、玉米油40%、低芥酸菜籽油5%、高油酸葵花籽油5%、椰子油5%)、复配矿物质0.13%(按质量百分比计,包括以下原料组分:无水硫酸铜0.62%、碘酸钾5.40%、硫酸亚铁16.86%、硫酸镁49.35%、硫酸锌7.33%)、复配维生素0.48%(按质量百分比计,包括以下原料组分:醋酸视黄酯1.23%、胆钙化醇0.71%、α-醋酸生育酚4.58%、植物甲萘醌0.16%、硝酸硫胺素0.15%、核黄素0.07%、盐酸吡哆醇0.12%、L-抗坏血酸钠66%、D-泛酸钙0.62%、D-生物素0.31%、叶酸0.17%、烟酰胺0.94%、氰钴胺0.31%、叶黄素0.94%)、二十二碳六烯酸(DHA) 0.18%(以纯品计)、花生四烯酸(ARA) 0.22%(以纯品计)、胆碱0.015%和纯净水。Based on the nutritional requirements of infants from 6 to 12 months old, fresh milk, whey protein powder, vegetable oil, lactose are used as the main raw materials, and multivitamins, minerals, taurine, inositol, choline, etc. are added. In terms of weight percentage, it includes the following components: 25% fresh milk, 0.95% whey protein powder, 5.75% lactose, 2.58% vegetable blend oil (in terms of mass percentage, including the following raw material components: soybean oil 45%, corn oil 40 %, canola oil 5%, high oleic sunflower oil 5%, coconut oil 5%), compound mineral 0.13% (based on mass percentage, including the following raw material components: anhydrous copper sulfate 0.62% , Potassium iodate 5.40%, ferrous sulfate 16.86%, magnesium sulfate 49.35%, zinc sulfate 7.33%), compound vitamin 0.48% (by mass percentage, including the following raw material components: retinyl acetate 1.23%, cholecalcification Alcohol 0.71%, alpha-tocopherol acetate 4.58%, plant menadione 0.16%, thiamine nitrate 0.15%, riboflavin 0.07%, pyridoxine hydrochloride 0.12%, L-sodium ascorbate 66%, D-calcium pantothenate 0.62%, D-biotin 0.31%, folic acid 0.17%, nicotinamide 0.94%, cyanocobalamin 0.31%, lutein 0.94%), docosahexaenoic acid (DHA) 0.18% (based on pure product), arachidonic acid (ARA) 0.22% (calculated as pure product), 0.015% choline and purified water.
主要包括以下几个步骤:It mainly includes the following steps:
步骤1:取新鲜牛乳,测量乳中的蛋白质、乳糖、乳脂以及矿物质;Step 1: Take fresh milk and measure the protein, lactose, milk fat and minerals in the milk;
步骤2:以6~12个月的婴儿的营养素需求计算婴幼儿配方乳中宏量营养素的含量;Step 2: Calculate the content of macronutrients in infant formula milk based on the nutrient requirements of infants aged 6-12 months;
步骤3:乳清蛋白粉、植物调和油、乳糖、磷脂、DHA和ARA使用40~50 ℃的纯净水混合溶解,进行充分搅拌;Step 3: Use 40-50 for whey protein powder, vegetable oil, lactose, phospholipids, DHA and ARA Mix and dissolve in pure water at ℃ and stir thoroughly;
步骤4:将复配矿物质预混料、复配维生素预混料分别在各专用容器中用40~50℃的纯净水溶解,分步添加到步骤1的混料中进行充分混合,复配矿物质和复配维生素添加混合时间应≥15min,再添加肌醇、胆碱、牛磺酸,充分混合;Step 4: Dissolve the compound mineral premix and compound vitamin premix in each special container with purified water at 40~50℃, and add them step by step to the mixture of step 1 for thorough mixing and compounding The time for adding and mixing minerals and compound vitamins should be ≥15min, then add inositol, choline, and taurine and mix thoroughly;
步骤5:均质:将上述混合物料进行均质,均质压力为25~30 MPa,均质1~2遍;Step 5: Homogenization: homogenize the above-mentioned mixture at a homogenization pressure of 25-30 MPa, homogenize 1 to 2 times;
步骤6:将均质过的液态乳进行杀菌(75℃,15s);Step 6: Sterilize the homogenized liquid milk (75°C, 15s);
步骤7:无菌灌装后冷链运输、低温冷藏(4℃条件下)。Step 7: Cold chain transportation after aseptic filling, low temperature storage (under 4℃).
实施例2Example 2
一种含有活性蛋白的幼儿(12~24个月)牛乳基液态配方奶A kind of milk-based liquid formula milk for children (12-24 months) containing active protein
以12~24个月的幼儿营养素需求为标准,以新鲜牛乳、乳清蛋白粉、植物调和油、乳糖为主要原料,添加复合维生素、矿物质,牛磺酸、肌醇、胆碱等。按重量百分比计包括以下组分:鲜牛乳25%、乳清蛋白粉1.35%、乳糖8.35%、植物调和油2.28%(按质量百分比计,包括以下原料组分:大豆油45%、玉米油40%、低芥酸菜籽油5%、高油酸葵花籽油5%)、复配矿物质0.13%(按质量百分比计,包括以下原料组分:无水硫酸铜0.62%、碘酸钾5.40%、硫酸亚铁16.86%、硫酸镁49.35%、硫酸锌7.33%)、复配维生素0.48%(按质量百分比计,包括以下原料组分:醋酸视黄酯1.23%、胆钙化醇0.71%、α-醋酸生育酚4.58%、植物甲萘醌0.16%、硝酸硫胺素0.15%、核黄素0.07%、盐酸吡哆醇0.12%、L-抗坏血酸钠66%、D-泛酸钙0.62%、D-生物素0.31%、叶酸0.17%、烟酰胺0.94%、氰钴胺0.31%、叶黄素0.94%)、二十二碳六烯酸(DHA)粉末0.18%、花生四烯酸(ARA)粉末0.22%、胆碱0.015%和纯净水。Based on the nutritional requirements of children aged 12 to 24 months, fresh milk, whey protein powder, vegetable oil, lactose are used as the main raw materials, and multi-vitamins, minerals, taurine, inositol, choline, etc. are added. In terms of weight percentage, it includes the following components: 25% fresh milk, 1.35% whey protein powder, 8.35% lactose, 2.28% vegetable blend oil (by mass percentage, including the following raw material components: soybean oil 45%, corn oil 40 %, canola oil 5%, high oleic sunflower oil 5%), compound mineral 0.13% (calculated by mass percentage, including the following raw materials: anhydrous copper sulfate 0.62%, potassium iodate 5.40 %, ferrous sulfate 16.86%, magnesium sulfate 49.35%, zinc sulfate 7.33%), compound vitamin 0.48% (by mass percentage, including the following raw material components: retinyl acetate 1.23%, cholecalciferol 0.71%, α -Tocopherol acetate 4.58%, plant menadione 0.16%, thiamine nitrate 0.15%, riboflavin 0.07%, pyridoxine hydrochloride 0.12%, L-sodium ascorbate 66%, D-calcium pantothenate 0.62%, D- Biotin 0.31%, folic acid 0.17%, nicotinamide 0.94%, cyanocobalamin 0.31%, lutein 0.94%), docosahexaenoic acid (DHA) powder 0.18%, arachidonic acid (ARA) powder 0.22 %, Choline 0.015% and purified water.
主要包括以下几个步骤:It mainly includes the following steps:
步骤1:取新鲜牛乳,测量乳中的蛋白质、乳糖、乳脂以及矿物质;Step 1: Take fresh milk and measure the protein, lactose, milk fat and minerals in the milk;
步骤2:以6~12个月的婴儿的营养素需求计算婴幼儿配方乳中宏量营养素的含量;Step 2: Calculate the content of macronutrients in infant formula milk based on the nutrient requirements of infants aged 6-12 months;
步骤3:乳清蛋白粉、植物调和油、乳糖、磷脂使用40~50 ℃的纯净水混合溶解,进行充分搅拌;Step 3: Use 40-50 for whey protein powder, vegetable oil, lactose and phospholipids Mix and dissolve in pure water at ℃ and stir thoroughly;
步骤4:将复配矿物质预混料、复配维生素预混料分别在各专用容器中用40~50 ℃的纯净水溶解,分步添加到步骤1的混料中进行充分混合,复配矿物质和复配维生素添加混合时间应≥15min,再添加肌醇、胆碱、牛磺酸、DHA和ARA,充分混合;Step 4: Use 40-50 compound mineral premix and compound vitamin premix in each special container respectively Dissolve in pure water at ℃, add step by step to the mixture of step 1 and mix thoroughly. The mixing time for compound minerals and compound vitamins should be ≥15min, and then add inositol, choline, taurine, DHA and ARA , Fully mixed;
步骤5:均质:将上述混合物料进行均质,均质压力为20-30 MPa,均质1-2遍;Step 5: Homogenization: homogenize the above-mentioned mixture at a homogenization pressure of 20-30 MPa, homogenize 1-2 times;
步骤6:将均质过的液态乳进行杀菌(75℃,15s);Step 6: Sterilize the homogenized liquid milk (75°C, 15s);
步骤7:无菌灌装后冷链运输、低温冷藏(4℃条件下)。Step 7: Cold chain transportation after aseptic filling, low temperature storage (under 4℃).
实施例3Example 3
一种含有活性蛋白的较大婴儿(6-12个月)羊乳基液态配方奶A goat milk-based liquid formula for older babies (6-12 months) containing active protein
以6~12个月的婴儿营养素需求为标准,以新鲜羊乳、乳清蛋白粉、植物调和油、乳糖为主要原料,添加复合维生素、矿物质、牛磺酸、肌醇、胆碱等。按重量百分比计包括以下组分:鲜羊乳25%、乳清蛋白粉0.95%、乳糖5.75%、植物调和油2.58%(按质量百分比计,包括以下原料组分:大豆油45%、玉米油40%、低芥酸菜籽油5%、高油酸葵花籽油5%、椰子油5%)、复配矿物质0.13%(按质量百分比计,包括以下原料组分:无水硫酸铜0.62%、碘酸钾5.40%、硫酸亚铁16.86%、硫酸镁49.35%、硫酸锌7.33%)、复配维生素0.48%(按质量百分比计,包括以下原料组分:醋酸视黄酯1.23%、胆钙化醇0.71%、α-醋酸生育酚4.58%、植物甲萘醌0.16%、硝酸硫胺素0.15%、核黄素0.07%、盐酸吡哆醇0.12%、L-抗坏血酸钠66%、D-泛酸钙0.62%、D-生物素0.31%、叶酸0.17%、烟酰胺0.94%、氰钴胺0.31%、叶黄素0.94%)、二十二碳六烯酸(DHA) 0.18%(以纯品计)、花生四烯酸(ARA) 0.22%(以纯品计)、胆碱0.015%和纯净水。Based on the nutritional requirements of infants from 6 to 12 months old, fresh goat milk, whey protein powder, vegetable oil, lactose are used as the main raw materials, and multivitamins, minerals, taurine, inositol, choline, etc. are added. In terms of weight percentage, it includes the following components: 25% fresh goat milk, 0.95% whey protein powder, 5.75% lactose, 2.58% vegetable blend oil (by mass percentage, including the following raw material components: soybean oil 45%, corn oil 40%, canola oil 5%, high oleic sunflower oil 5%, coconut oil 5%), compound mineral 0.13% (based on mass percentage, including the following raw material components: anhydrous copper sulfate 0.62 %, potassium iodate 5.40%, ferrous sulfate 16.86%, magnesium sulfate 49.35%, zinc sulfate 7.33%), compound vitamin 0.48% (by mass percentage, including the following raw material components: retinyl acetate 1.23%, bile Calciferol 0.71%, alpha-tocopherol acetate 4.58%, plant menadione 0.16%, thiamine nitrate 0.15%, riboflavin 0.07%, pyridoxine hydrochloride 0.12%, L-sodium ascorbate 66%, D-pantothenic acid Calcium 0.62%, D-biotin 0.31%, folic acid 0.17%, nicotinamide 0.94%, cyanocobalamin 0.31%, lutein 0.94%), docosahexaenoic acid (DHA) 0.18% (based on pure product), arachidonic acid (ARA) 0.22% (calculated as pure product), 0.015% choline and purified water.
主要包括以下几个步骤:It mainly includes the following steps:
步骤1:取新鲜羊乳,测量乳中的蛋白质、乳糖、乳脂以及矿物质;Step 1: Take fresh goat milk and measure the protein, lactose, milk fat and minerals in the milk;
步骤2:以6~12个月的婴儿的营养素需求计算婴幼儿配方液态奶中宏量营养素的含量;Step 2: Calculate the content of macronutrients in liquid milk formula for infants and young children based on the nutrient requirements of infants aged 6-12 months;
步骤3:乳清蛋白粉、植物调和油、乳糖、磷脂、DHA和ARA使用40~50 ℃的纯净水混合溶解,进行充分搅拌;Step 3: Use 40-50 for whey protein powder, vegetable oil, lactose, phospholipids, DHA and ARA Mix and dissolve in pure water at ℃ and stir thoroughly;
步骤4:将复配矿物质预混料、复配维生素预混料分别在各专用容器中用40~50℃的纯净水溶解,分步添加到步骤1的混料中进行充分混合,复配矿物质和复配维生素添加混合时间应≥15min,再添加肌醇、胆碱、牛磺酸,充分混合;Step 4: Dissolve the compound mineral premix and compound vitamin premix in each special container with purified water at 40~50℃, and add them step by step to the mixture of step 1 for thorough mixing and compounding The time for adding and mixing minerals and compound vitamins should be ≥15min, then add inositol, choline, and taurine and mix thoroughly;
步骤5:均质:将上述混合物料进行均质,均质压力为25~30 MPa,均质1~2遍;Step 5: Homogenization: homogenize the above-mentioned mixture at a homogenization pressure of 25-30 MPa, homogenize 1 to 2 times;
步骤6:将均质过的液态奶进行杀菌(65℃,30min);Step 6: Sterilize the homogenized liquid milk (65°C, 30min);
步骤7:无菌灌装后冷链运输、低温冷藏(4℃条件下)。Step 7: Cold chain transportation after aseptic filling, low temperature storage (under 4℃).
实施例4Example 4
以实施例1中获得的婴儿液态配方奶为例,再次使用酶联免疫的方法比较不同工艺生产的婴儿配方奶中的免疫球蛋白(IgA、IgG和IgM)和乳铁蛋白含量,同时采用SDS-凝胶电泳和LC-MS/MS蛋白组学手段鉴定乳清蛋白中低丰度蛋白的种类及含量变化。具体测试过程和结果分析如下:Taking the infant liquid formula obtained in Example 1 as an example, the enzyme-linked immunoassay method was used to compare the immunoglobulin (IgA, IgG and IgM) and lactoferrin content in infant formula produced by different processes, and SDS was used at the same time. -Gel electrophoresis and LC-MS/MS proteomics methods to identify the types and content changes of low-abundance proteins in whey protein. The specific test process and result analysis are as follows:
(一)实验原料、试剂和仪器(1) Experimental materials, reagents and instruments
鲜乳购于江苏省无锡市天资乳业有限公司,免疫球蛋白试剂检测盒(Elisa Kit)购自美国Bethyl公司,LC-MS/MS所用液相色谱为美国Thermo Fisher Scientific Ultimate 3000毛细管高效液相色谱仪,质谱为Thermo Fisher Scientific Q Exactive电喷雾-组合型离子阱Orbitrap 质谱仪。所用毛细管液相色谱柱均为PepMap RPLC C18预装柱。流动相A:0.1%甲酸,2%ACN;流动相B:0.1%甲酸,80%ACN;流速:300 nL/min。Fresh milk was purchased from Wuxi Tianzi Dairy Co., Ltd., Jiangsu Province, and the immunoglobulin test kit (Elisa Kit) was purchased from Bethyl Company, USA. The liquid chromatography used for LC-MS/MS was from USA Thermo Fisher Scientific Ultimate 3000 capillary high performance liquid chromatograph, mass spectrometer is Thermo Fisher Scientific Q Exactive Electrospray-Combined Ion Trap Orbitrap Mass spectrometer. All capillary liquid chromatography columns used are PepMap RPLC C18 prepacked column. Mobile phase A: 0.1% formic acid, 2% ACN; mobile phase B: 0.1% formic acid, 80% ACN; flow rate: 300 nL/min.
(二)实验过程(2) Experimental process
选购市售6种婴幼儿配方乳粉及常温储存型婴幼儿配方液态奶进行免疫球蛋白和乳铁蛋白含量的测定,将乳粉按照相同质量分数的固形物比例溶解于去离子水中后稀释,其中液态乳直接进行500-1000倍稀释(确保在试剂盒检测范围内),随后进行免疫球蛋白和乳铁蛋白含量的测定。Purchase 6 kinds of commercially available infant formula milk powder and normal temperature storage type infant formula liquid milk for the determination of immunoglobulin and lactoferrin content, and dissolve the milk powder in deionized water at the same mass fraction of solid content and then dilute , The liquid milk is directly diluted 500-1000 times (to ensure that it is within the detection range of the kit), and then the content of immunoglobulin and lactoferrin is determined.
按照实施例1制备新鲜的液态婴配样品(R组),进行不同的热处理工艺进行杀菌。杀菌条件分别为65℃,30min(L组)、75℃,15s(H组)、125℃,5s(E组)、135℃,5s(U组)和喷雾干燥(95℃杀菌15min后,喷雾干燥,进风温度185℃,出风温度85℃,S组)。将不同处理组样品经过超高速离心(美国Beckman Coulter离心机,100000g,25℃,90min)后得到乳清后进行免疫球蛋白和乳铁蛋白含量测定(每个样品做两个平行孔),SDS凝胶电泳实验,胰蛋白酶(Trypsin)酶解和LC-MS/MS 蛋白组实验(每个样品做两个平行)。酶解操作如下:Prepare fresh liquid infant formula samples (group R) according to Example 1, and perform different heat treatment processes for sterilization. Sterilization conditions were 65°C, 30min (L group), 75°C, 15s (H group), 125°C, 5s (E group), 135°C, 5s (U group) and spray drying (95°C sterilization for 15 minutes, spray Dry, inlet air temperature is 185°C, outlet air temperature is 85°C, S group). The samples of different treatment groups were subjected to ultra-high-speed centrifugation (Beckman, USA) Coulter centrifuge, 100000g, 25°C, 90min) After obtaining the whey, the immunoglobulin and lactoferrin content determination (two parallel holes for each sample), SDS gel electrophoresis experiment, trypsin digestion And LC-MS/MS Proteomics experiment (two parallels for each sample). The enzymolysis operation is as follows:
1)   取100 μg蛋白转移至10 kD超滤管中,加入50 mmol/L NH 4HCO 3溶液至200 μL,于4 ℃在12000 rcf速度下离心10 min。 1) Transfer 100 μg of protein to a 10 kD ultrafiltration tube, add 50 mmol/L NH 4 HCO 3 solution to 200 μL, and centrifuge at 4 ℃ and 12000 rcf for 10 min.
2)   加入50 mmol/L NH 4HCO 3溶液200 μL,于4 ℃在12000 rcf速度下离心10 min,并重复操作两次,直至溶液变为无色透明。 2) Add 200 μL of 50 mmol/L NH 4 HCO 3 solution, centrifuge at 4 ℃ at 12000 rcf for 10 min, and repeat the operation twice until the solution becomes colorless and transparent.
3)   加入50 mmol/L NH 4HCO 3溶液50 μL,加入DTT溶液使其终浓度为10 mmol/L,于37 ℃水浴中还原4 h。 3) Add 50 μL of 50 mmol/L NH 4 HCO 3 solution, add DTT solution to make the final concentration 10 mmol/L, and reduce in a 37 ℃ water bath for 4 h.
4)   加入IAA溶液使其终浓度为50 mmol/L,避光反应40 min后,于4 ℃在12000 rcf速度下离心10 min。4) Add the IAA solution to make the final concentration 50 mmol/L, dark reaction 40 min after 4 °C at 12000 Centrifuge at rcf speed 10 min.
5)   加入50 mmol/L NH 4HCO 3溶液100 μL,于4 ℃在12000 rcf速度下离心10 min。 5) Add 100 μL of 50 mmol/L NH 4 HCO 3 solution and centrifuge at 12000 rcf for 10 min at 4 ℃.
6)   更换新的套管,于超滤管中加入50 μL 50 mmol/L NH 4HCO 3溶液,按照胰蛋白酶与底物质量比为1:100加入胰蛋白酶,37 ℃酶切4小时,继续按质量比1:100加入胰酶,37 ℃酶切反应过夜(16 h)。 6) Replace with a new cannula, add 50 μL of 50 mmol/L NH 4 HCO 3 solution to the ultrafiltration tube, add trypsin according to the mass ratio of trypsin to substrate 1:100, digest at 37 ℃ for 4 hours, continue Add pancreatin at a mass ratio of 1:100, and digest at 37°C overnight (16 h).
7)   于4 ℃在12000 rcf速度下离心10 min,加入100 μL水,涡旋后,于4℃在12000 rcf速度下离心10 min,并重复操作一次。7) At 4 °C at 12000 Centrifuge at rcf speed 10 min, add 100 μL water, after vortexing, at 12000 at 4℃ Centrifuge at rcf speed 10 min, and repeat the operation once.
8)   酶切后肽段使用自填脱盐柱脱盐,于45 ℃真空离心浓缩仪中挥干溶剂。8) After digestion, the peptide fragments are desalted using self-packing desalting column. Evaporate the solvent in a vacuum centrifugal concentrator at ℃.
9)   肽段用样品溶解液(0.1%甲酸、2%乙腈)溶解,充分振荡涡旋,13200 rpm,4 ℃离心10 min,上清转移到上样管中,等待质谱分析。一级质谱参数:Resolution:70,000;AGCtarget:3e6;MaximumIT:40 ms;Scanrange:350到1800 m/z;9) Dissolve the peptide with sample dissolving solution (0.1% formic acid, 2% acetonitrile), vortex thoroughly, 13200 rpm, 4 Centrifuge at ℃ 10 min, transfer the supernatant to the sample tube and wait for mass spectrometry analysis. Mass spectrometry parameters: Resolution: 70,000; AGCtarget: 3e6; MaximumIT: 40 ms; Scanrange: 350 to 1800 m/z;
二级质谱参数:Resolution:75,000;AGCtarget:1e5;MaximumIT:60 ms;Two-stage mass spectrometry parameters: Resolution: 75,000; AGCtarget: 1e5; MaximumIT: 60 ms;
TopN:20;NCE/steppedNCE:27。质谱原始文件使用Maxquant (1.6.2.10)检索uniprot-Bos taurus数据库,鉴定出的蛋白的生物学功能使用Uniprot数据进行检索。TopN: 20; NCE/steppedNCE: 27. Mass spectrometry raw files use Maxquant (1.6.2.10) Search the uniprot-Bos taurus database, and use Uniprot data to search the biological functions of the identified proteins.
由图2和图3可知,鲜乳经过不同的热杀菌处理方式后,其中的免疫相关的活性蛋白的保留率出现显著差异,不同热处理后乳中活性蛋白保留率以鲜牛乳或羊乳中活性蛋白含量为对照计算得到。整体而言,两种巴氏杀菌方式(L组和H组)对活性蛋白的保留率较高,而经过ESL (Extended Shelf Life、延长货架期的巴氏杀菌方式) 处理(E组),UHT (Ultra High Temperature、超高温灭菌方式)处理(U组)和喷雾干燥处理(S组)后,乳中的免疫球蛋白均检测不到,含量几乎接近为0。因此,本发明所采用的热处理方式为巴氏杀菌,即72~75℃,15~20s或63~65℃,30~35min。From Figure 2 and Figure 3, it can be seen that after different heat sterilization treatments, the retention rate of immune-related active protein in fresh milk is significantly different. The retention rate of active protein in milk after different heat treatments is based on that in fresh milk or goat milk. The protein content is calculated from the control. On the whole, the two pasteurization methods (L group and H group) have a higher retention rate of active protein, and after ESL (Extended Shelf Life, pasteurization to extend shelf life) Treatment (Group E), UHT (Ultra After High Temperature and UHT treatment (group U) and spray drying treatment (group S), the immunoglobulins in the milk were not detected, and the content was almost close to zero. Therefore, the heat treatment method adopted in the present invention is pasteurization, that is, 72-75°C, 15-20s or 63-65°C, 30-35min.
由图4可以发现,E、U和S组处理后,鲜牛乳中乳清蛋白的类型发生了明显变化。其中,乳铁蛋白,牛血清白蛋白和重链免疫球蛋白的条带已经观察不到;此外,α-乳白蛋白和β-乳球蛋白的条带也减轻了许多,尤其是经过了UHT处理以后。因此,本发明选用L或者H的热处理方式对牛乳进行杀菌。From Figure 4, it can be found that the types of whey protein in fresh milk have changed significantly after the treatment of E, U and S groups. Among them, the bands of lactoferrin, bovine serum albumin and heavy chain immunoglobulin have not been observed; in addition, the bands of α-lactalbumin and β-lactoglobulin are also reduced a lot, especially after UHT treatment after. Therefore, the present invention uses L or H heat treatment to sterilize the milk.
由表1可以发现,与不经热处理的婴幼儿配方液态奶初始混合样品相比,经过两种巴氏杀菌制备的婴配终产品中免疫球蛋白和乳铁蛋白的含量有所下降,但均能得到很大程度的保留;但是H组,E组和S组的样品中均不含免疫球蛋白和乳铁蛋白。同时可以发现,从市面上购买的4种婴幼儿配方乳粉(分别为中国伊利公司金领冠1段、德国Pronutra 公司Aptamil2段、荷兰Nutricia公司Nutrilon1段、爱尔兰惠氏公司启赋2段),2种常温婴幼儿配方液态奶:美国进口美赞臣公司(Mead Johnson & Company)Enfagrow幼儿配方液态奶和法国进口圣元公司(Synutra)布瑞弗尼幼儿配方液态奶以及1种荷兰进口全脂乳粉(Dutch Cow)经过试验测试,均检测不到具有活性的免疫球蛋白和乳铁蛋白。因此,本发明选用低温热杀菌的方式制备液态婴幼儿配方乳制品。 It can be found from Table 1 that compared with the initial mixed sample of liquid milk formula for infants and young children without heat treatment, the contents of immunoglobulin and lactoferrin in the final product of infant formula prepared by two pasteurizations decreased, but both A large degree of retention can be obtained; however, the samples of group H, group E and group S do not contain immunoglobulin and lactoferrin. At the same time, it can be found that 4 kinds of infant formula milk powders purchased from the market (respectively are China Yili Company Golden Collar Crown 1st paragraph, German Pronutra + Company Aptamil 2nd paragraph, Dutch Nutricia Company Nutrilon 1st paragraph, Irish Wyeth Company Qifu 2nd paragraph), 2 Two kinds of liquid milk formula for infants and young children at room temperature: Mead Johnson & Company imported from the United States (Mead Johnson & Company) Enfagrow infant formula milk, France imported from France (Synutra) Briveni infant formula liquid milk and 1 type of Dutch imported whole milk powder Dutch Cow) has been tested and found that no active immunoglobulin and lactoferrin can be detected. Therefore, the present invention adopts low-temperature heat sterilization to prepare liquid infant formula milk products.
表1不同处理方式的牛乳基婴配样品与市售6种婴配产品种免疫球蛋白和乳铁蛋白含量比较Table 1 Comparison of immunoglobulin and lactoferrin content between milk-based infant formula samples with different treatment methods and 6 commercially available infant formula products
Figure dest_path_image001
Figure dest_path_image001
注:同一列的不同字母代表显著性差异(p<0.05),“-”表示检测不到。Note: Different letters in the same column represent significant differences (p<0.05), "-" means undetectable.
由鉴定到的蛋白质组数据可以发现,经过不同热处理的婴配样品中乳清蛋白的种类发生了很大变化。由主成分分析图可以发现,L组和H组聚集在一起,几乎不能被区分开,而E、U和S组则聚集在一起。为了方便分析,接下来的实验将L和H归为低温处理组,将E、U和S归为高温处理组,进行生物信息学分析。From the identified proteomic data, it can be found that the types of whey protein in the infant formula samples after different heat treatment have undergone great changes. From the principal component analysis graph, it can be found that the L group and the H group are clustered together and can hardly be distinguished, while the E, U and S groups are clustered together. In order to facilitate the analysis, the following experiments will classify L and H into the low-temperature treatment group, and classify E, U and S into the high-temperature treatment group for bioinformatics analysis.
由图5和图6可以看出,经过高温组处理后,乳清中的热敏性蛋白的含量发生了明显的变化,其中补体蛋白C3、乳铁蛋白、叶酸受体蛋白、脂质运载蛋白等的含量发生了显著的下降。同时经过高热处理后的乳清中也有一些蛋白的丰度增加了,比如α酪蛋白和β酪蛋白,可能是因为加热过程中这些蛋白以二硫键的形式与乳清中的蛋白发生了键合作用而导致的。It can be seen from Figure 5 and Figure 6 that after the high temperature group treatment, the content of heat-sensitive proteins in whey has changed significantly, among which complement protein C3, lactoferrin, folate receptor protein, lipocalin, etc. The content has dropped significantly. At the same time, the abundance of some proteins in the whey after high heat treatment, such as α-casein and β-casein, may be due to the disulfide bonds between these proteins in the whey protein during the heating process. Caused by cooperation.
表2列出了经过高温处理后,乳中含量下降以及缺少损失的低丰度乳清蛋白,这些蛋白主要包含酶、补体蛋白、结构蛋白等,涉及催化、免疫、黏合等诸多生理活动。结果表明,使用本发明采用热处理方法制备的婴幼儿配方液态奶保留了含量较高的活性蛋白,如免疫球蛋白、乳铁蛋白、补体蛋白、乳凝集素等。Table 2 lists the low-abundance whey proteins that have decreased content and lack of loss after high temperature treatment. These proteins mainly include enzymes, complement proteins, structural proteins, etc., and involve many physiological activities such as catalysis, immunity, and adhesion. The results show that the liquid milk formula for infants and young children prepared by the heat treatment method of the present invention retains a higher content of active proteins, such as immunoglobulin, lactoferrin, complement protein, lactectin, etc.
表2高温处理组与低温处理组蛋白含量对比Table 2 Comparison of protein content between high temperature treatment group and low temperature treatment group
Figure dest_path_image002
Figure dest_path_image002
注:“-”表示不适用。Note: "-" means not applicable.
虽然本发明已以较佳实施例公开如上,但其并非用以限定本发明,任何熟悉此技术的人,在不脱离本发明的精神和范围内,都可做各种的改动与修饰,因此本发明的保护范围应该以权利要求书所界定的为准。Although the present invention has been disclosed as above in preferred embodiments, it is not intended to limit the present invention. Anyone familiar with this technology can make various changes and modifications without departing from the spirit and scope of the present invention. The protection scope of the present invention should be defined by the claims.

Claims (15)

  1. 一种含活性蛋白的乳基婴幼儿配方液态奶制备方法,其特征在于,所述制备方法包括将液态新鲜牛乳或羊乳与其他营养素进行调配、均质、热杀菌处理,所述热杀菌处理是利用巴氏杀菌72~75℃处理15~20s或63~65℃处理30~40 min。A preparation method of milk-based infant formula liquid milk containing active protein, characterized in that, the preparation method comprises mixing, homogenizing, and heat sterilizing liquid fresh milk or goat milk with other nutrients. It is pasteurized at 72~75℃ for 15~20s or 63~65℃ for 30~40 min.
  2. 一种含活性蛋白的乳基婴幼儿配方液态奶制备方法,其特征在于,所述制备方法包括将液态新鲜牛乳或羊乳与其他营养素进行调配、均质、热杀菌处理,所述热杀菌处理是利用巴氏杀菌70~85 ℃处理12~30s或62.5~70℃处理30~40 min。A preparation method of milk-based infant formula liquid milk containing active protein, characterized in that, the preparation method comprises mixing, homogenizing, and heat sterilizing liquid fresh milk or goat milk with other nutrients. It is pasteurized at 70~85 ℃ for 12~30s or 62.5~70℃ for 30~40 min.
  3. 如权利要求1或2所述的乳基婴幼儿配方液态奶制备方法,其特征在于,所述制备方法包括以下步骤:The preparation method of milk-based infant formula liquid milk according to claim 1 or 2, wherein the preparation method comprises the following steps:
    (1)取新鲜牛乳或羊乳,测定其中蛋白质、乳糖、脂肪和矿物质的含量;(1) Take fresh milk or goat milk and determine the content of protein, lactose, fat and minerals;
    (2)按照食品安全国家标准GB 10765-2010计算婴幼儿配方液态乳中所需营养素的含量;(2) According to the national food safety standard GB 10765-2010 Calculate the content of nutrients required in liquid milk formula for infants and young children;
    (3)将乳清蛋白粉、植物调和油、乳糖、磷脂、DHA和ARA使用纯净水混合溶解,进行充分搅拌后与新鲜牛乳或羊乳混合均匀,使得到的混料中乳清蛋白粉、植物调和油、乳糖、磷脂、DHA和ARA含量符合步骤(2)中的计算结果;(3) Mix whey protein powder, plant blended oil, lactose, phospholipids, DHA and ARA with purified water to dissolve it, stir thoroughly and mix with fresh milk or goat milk evenly, so that the resulting mixture contains whey protein powder, The content of plant blend oil, lactose, phospholipid, DHA and ARA meet the calculation results in step (2);
    (4)将复配矿物质预混料、复配维生素预混料分别用纯净水溶解,分步添加到步骤(3)得到的混料中进行充分混合,添加复配矿物质、复配维生素时,混合时间均不低于15 min,再添加肌醇、胆碱、牛磺酸,充分混合,使得到的混料中复配矿物质、复配维生素、肌醇、胆碱、牛磺酸含量符合步骤(2)中的计算结果;(4) Dissolve the compound mineral premix and compound vitamin premix with purified water respectively, add step by step to the mixture obtained in step (3) and mix thoroughly, add compound minerals and compound vitamins When the mixing time is not less than 15 minutes, add inositol, choline, and taurine and mix thoroughly so that the resulting mixture is compounded with minerals, compound vitamins, inositol, choline, and taurine The content meets the calculation result in step (2);
    (5)均质;(5) Homogenization;
    (6)将均质过的液态乳进行杀菌,利用巴氏杀菌72~75℃处理15~20s或63~65℃处理30~40 min。(6) Sterilize the homogenized liquid milk, and use pasteurization at 72~75℃ for 15~20s or 63~65℃ for 30~40 min.
  4. 如权利要求3所述的乳基婴幼儿配方液态奶制备方法,其特征在于,步骤(1)通过电感耦合等离子体质谱ICP-MS测定乳中矿物质的含量。The method for preparing milk-based infant formula liquid milk according to claim 3, wherein the step (1) determines the content of minerals in the milk by inductively coupled plasma mass spectrometry (ICP-MS).
  5. 如权利要求3所述的乳基婴幼儿配方液态奶制备方法,其特征在于,添加乳清蛋白粉使乳中乳清蛋白与酪蛋白比例≥3:2。The method for preparing milk-based infant formula liquid milk according to claim 3, wherein the whey protein powder is added so that the ratio of whey protein to casein in the milk is ≥3:2.
  6. 如权利要求5所述的乳基婴幼儿配方液态奶制备方法,其特征在于,所述乳基婴幼儿配方液态奶中总蛋白含量为1.0~2.5 g/100mL。The method for preparing liquid milk-based infant formula milk according to claim 5, wherein the total protein content in the liquid milk-based infant formula milk is 1.0-2.5 g/100mL.
  7. 如权利要求3所述的乳基婴幼儿配方液态奶制备方法,其特征在于,步骤(3)与步骤(4)中的纯净水温度为40~50℃。The method for preparing milk-based infant formula liquid milk according to claim 3, wherein the temperature of the purified water in step (3) and step (4) is 40-50°C.
  8. 如权利要求3所述的乳基婴幼儿配方液态奶制备方法,其特征在于,所述均质的条件为20~30 MPa。The method for preparing milk-based infant formula liquid milk according to claim 3, wherein the homogenization condition is 20-30 MPa.
  9. 如权利要求3所述的乳基婴幼儿配方液态奶制备方法,其特征在于,所述均质的次数为1~2次。The method for preparing milk-based infant formula liquid milk according to claim 3, wherein the number of homogenization is 1 to 2 times.
  10. 如权利要求3所述的乳基婴幼儿配方液态奶制备方法,其特征在于,杀菌后无菌灌装,冷链运输或低温冷藏。The method for preparing milk-based infant formula liquid milk according to claim 3, wherein after sterilization, aseptic filling, cold chain transportation or low temperature refrigeration.
  11. 如权利要求1所述的乳基婴幼儿配方液态奶制备方法,其特征在于,所述活性蛋白包括乳铁蛋白、免疫球蛋白IgG、IgA、IgM、乳过氧化物酶、补体蛋白C3、核糖核酸酶、脂质运载蛋白-2、乳凝集素或其结合。The method for preparing milk-based infant formula liquid milk according to claim 1, wherein the active protein comprises lactoferrin, immunoglobulin IgG, IgA, IgM, lactoperoxidase, complement protein C3, ribose Nuclease, lipocalin-2, lactectin or a combination thereof.
  12. 如权利要求1所述的乳基婴幼儿配方液态奶制备方法,其特征在于,所述营养素包括乳清蛋白粉、植物调和油、乳糖和磷脂。The method for preparing milk-based infant formula liquid milk according to claim 1, wherein the nutrients include whey protein powder, vegetable oil, lactose and phospholipids.
  13. 如权利要求12所述的乳基婴幼儿配方液态奶制备方法,其特征在于,所述营养素还包括DHA、ARA、复配矿物质和复配维生素。The method for preparing milk-based infant formula liquid milk according to claim 12, wherein the nutrients further include DHA, ARA, compound minerals and compound vitamins.
  14. 权利要求1-13任一所述的乳基婴幼儿配方液态奶制备方法制备得到的婴幼儿配方奶。Infant formula milk prepared by the method for preparing milk-based infant formula liquid milk according to any one of claims 1-13.
  15. 权利要求1-13任一所述的乳基婴幼儿配方液态奶制备方法在食品领域的应用。Application of the method for preparing milk-based infant formula liquid milk according to any one of claims 1-13 in the food field.
PCT/CN2019/114535 2019-08-21 2019-10-31 Milk-based liquid infant formula containing active proteins, and preparation method therefor WO2021031348A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201910774333.2 2019-08-21
CN201910774333.2A CN110367336A (en) 2019-08-21 2019-08-21 A kind of newborn base baby formula liquid milk and preparation method thereof containing activated protein

Publications (1)

Publication Number Publication Date
WO2021031348A1 true WO2021031348A1 (en) 2021-02-25

Family

ID=68260247

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2019/114535 WO2021031348A1 (en) 2019-08-21 2019-10-31 Milk-based liquid infant formula containing active proteins, and preparation method therefor

Country Status (2)

Country Link
CN (1) CN110367336A (en)
WO (1) WO2021031348A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110367336A (en) * 2019-08-21 2019-10-25 江南大学 A kind of newborn base baby formula liquid milk and preparation method thereof containing activated protein
CN111789160A (en) * 2020-05-29 2020-10-20 李庆雷 Three-segment liquid milk for infants
CN111838318B (en) * 2020-07-13 2022-12-30 江南大学 Process for improving structure and components of homogenized milk fat globule membrane by using phospholipid

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103392810A (en) * 2013-07-18 2013-11-20 河北国绿食生物科技有限公司 Humanized dairy product and preparation method thereof
CN110367336A (en) * 2019-08-21 2019-10-25 江南大学 A kind of newborn base baby formula liquid milk and preparation method thereof containing activated protein

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101218942B (en) * 2008-02-02 2012-01-25 内蒙古蒙牛乳业(集团)股份有限公司 Serum albumin added liquid condition milk for baby
CN102511557B (en) * 2011-12-29 2015-06-17 内蒙古伊利实业集团股份有限公司 Liquid infant milk for newborn to six-month-old infant and production method thereof
CN102919365B (en) * 2012-11-08 2014-03-26 光明乳业股份有限公司 Liquid dairy product rich in immune globulin and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103392810A (en) * 2013-07-18 2013-11-20 河北国绿食生物科技有限公司 Humanized dairy product and preparation method thereof
CN110367336A (en) * 2019-08-21 2019-10-25 江南大学 A kind of newborn base baby formula liquid milk and preparation method thereof containing activated protein

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
OU GUOBING, XIA SHIREN, TONG GANGPING: "Factors affecting the quality of pasteurized milk and its control", XINJIANG ANIMAL HUSBANDRY, no. 8, 10 August 2010 (2010-08-10), pages 19 - 21, XP055783501, DOI: 10.16795/j.cnki.xjxmy.2010.08.008 *

Also Published As

Publication number Publication date
CN110367336A (en) 2019-10-25

Similar Documents

Publication Publication Date Title
Goulding et al. Milk proteins: An overview
US20210161164A1 (en) Human milk compositions and methods of making and using same
WO2021031348A1 (en) Milk-based liquid infant formula containing active proteins, and preparation method therefor
DONOVAN et al. Non‐protein nitrogen and true protein in infant formulas
TWI355239B (en) Low-lactose partially hydrolyzed infant formula
JP4317455B2 (en) Compositions for infant formulas containing large amounts of alpha-lactalbumin
JP5448819B2 (en) Methods for obtaining sterile milk and compositions thereof
CN111990462A (en) Infant formula containing protein composition and preparation method thereof
Villas-Boas et al. The effect of transglutaminase-induced polymerization in the presence of cysteine on β-lactoglobulin antigenicity
Liu et al. Changes in bioactive milk serum proteins during milk powder processing
JP2008512398A (en) Human milk fortifier and its manufacturing method
Liu et al. Characterizing the changes of bovine milk serum proteins after simulated industrial processing
Hambraeus et al. Nutritional aspects of milk proteins
Cao et al. Characterization and comparison of milk fat globule membrane N-glycoproteomes from human and bovine colostrum and mature milk
Ronghui The reasearch on the anti-fatigue effect of whey protein powder in basketball training
Yang et al. Quantitative proteomic analysis of whey proteins in the colostrum and mature milk of yak (Bos grunniens)
Sánchez et al. HPP in dairy products: Impact on quality and applications
Zhang et al. Comparative whey proteome profiling of donkey milk with human and cow milk
Hambraeus Importance of milk proteins in human nutrition: physiological aspects
Montagne et al. Dynamics of the main immunologically and nutritionally available proteins of human milk during lactation
Hahn et al. Comparisons of proteomic profiles of whey protein between donor human milk collected earlier than 3 months and 6 months after delivery
Conti et al. Proteomics of human milk
RU2106785C1 (en) Method of preparing product containing active milk-protein components and product prepared by this method
US7273632B2 (en) Additive for infant milk formulas
Al‐Awadi* et al. Determination of selenium concentration and its chemical forms in the milk of Kuwaiti and non‐Kuwaiti lactating mothers

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19942265

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19942265

Country of ref document: EP

Kind code of ref document: A1